RRM2 and hepatocellular carcinoma: Regarding RRM2, miRNA‐582‐3p has been found to act on the regulatory subunit M2 of ribonucleotide reductase, contributing to the inhibition of HCC development by regulating the Wnt/β‐catenin signaling pathway [30].